Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DB2116961 COPD Study
2013-001827-38Phase 3Completed
- Sponsor
- GSK
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Anoro Ellipta in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by GSK. Primary endpoint: Trough FEV1 on Treatment Day 85. Started May 2014; status: completed.
02
Drugs
Anoro Ellipta
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-001827-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001827-38.